论文部分内容阅读
目的:探讨醒脾养儿颗粒剂联合思密达治疗小儿轮状病毒性腹泻的临床治疗效果。方法选取2010年～2012年在我院接受治疗的96例轮状病毒性腹泻的患儿为研究对象,将其随即平均分成两组,实验组与对照组,各48例。对照组给予思密达治疗,实验组在给予思密达治疗的基础上给予醒脾养儿颗粒剂治疗,观察两组患者的临床治疗效果。结果:实验组48例患儿显效15例,有效30例,总有效率93.75%,显著高于对照组显效11例,有效22例,总有效率68.7%,两组比较存在显著性差异(P<0.05)。住院时间相比较实验组也明显优于对照组(P<0.05)。结论:醒脾养儿颗粒剂联合思密达治疗小儿轮状病毒性腹泻具有良好的临床疗效,治愈率高,疗效确切,同时又可以缩短患儿的住院时间,安全性高等特点,是治疗小儿轮状病毒性腹泻的重要方法。
Objective: To investigate the therapeutic effect of Xingpi Yangzi granule combined with Smecta on children with rotavirus diarrhea. Methods Ninety-six children with rotavirus diarrhea who were treated in our hospital from 2010 to 2012 were divided into two groups, experimental group and control group, with 48 cases in each group. The control group was treated with Smectite. The experimental group was treated with Smecta to give Xingpiyangzi granule treatment, and the clinical effects of the two groups were observed. Results: In the experimental group, 48 cases were markedly effective in 15 cases, effective in 30 cases, the total effective rate was 93.75%, significantly higher than the control group, 11 cases markedly effective in 22 cases, the total effective rate was 68.7%, there was significant difference between the two groups (P <0.05). Hospitalization time was also significantly better than the control group (P <0.05). Conclusion: Xingpi Yangzi granule combined with Smecta has good clinical curative effect on pediatric rotavirus diarrhea. The cure rate is high and curative effect is exact. At the same time, it can shorten the hospitalization time and safety of children, Viral diarrhea is an important method.